BioNordic A/S: Financial statements 2022
CVR: 40831622
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
BioNordic A/S (CVR 40831622) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 77,809,996 and a net result of DKK 5,156,853 compared with DKK 408,202 the year before. That is an increase of 92.9% compared with the year before. Equity in the 2022 report amounted to DKK 24,828,208. The solvency ratio was 6.3%. The company had 98 employees in the financial year.
- Gross Profit
- DKK 77,809,996
- Profit/Loss
- DKK 5,156,853
- Equity
- DKK 24,828,208
- Total Assets
- DKK 394,101,156
- Employees
- 98
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 77.8M | 5.2M | 24.8M | 98 |
| 2021 | - | 40.3M | 408K | 18.2M | 84 |
Official annual report
Keep an eye on BioNordic A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
BioNordic A/S has published its annual report for 2021. Gross profit came to DKK 40,331,968, and the net result was DKK 408,202.
As of March 1, 2022, Ole Bødtker Nielsen is registered as an owner of BioNordic A/S with an ownership share of 10%.
As of March 1, 2022, Stefan Bødtker Michelsen is registered as an owner of BioNordic A/S with an ownership share of 25%.
As of March 1, 2022, Nicolas Bødtker Nielsen is registered as an owner of BioNordic A/S with an ownership share of 25%.
As of March 1, 2022, Bettina Bødtker Nielsen is registered as an owner of BioNordic A/S with an ownership share of 25%.
As of March 1, 2022, Milena Gonzalez Murillo is registered as an owner of BioNordic A/S with an ownership share of 10%.
As of March 1, 2022, is registered as an owner of BioNordic A/S with an ownership share of 5%.
About BioNordic A/S
BioNordic A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Troels Zakarias Glahn Kristiansen. The board consists of Ole Bødtker Nielsen (chair), Lene Ploug Bülow and Nicolas Bødtker Nielsen. The company's owners include Ole Bødtker Nielsen, Stefan Bødtker Michelsen and Nicolas Bødtker Nielsen. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 49,188,844 and a net result of DKK 131,702,212 compared with DKK -20,860,483 the year before. Equity in the 2025 report amounted to DKK 163,782,004.